DISTRIBUTION, ISOLATION AND CHARACTERIZATION OF LYTIC BACTERIOPHAGES AGAINST MULTI-DRUG RESISTANT AND EXTENDED-SPECTRUM OF β-LACTAMASE PRODUCING PATHOGENS FROM HOSPITAL EFFLUENTS
Abstract
Objective: To isolate. Screen and characterize an effective phage for MDR and ESBL producing pathogenic bacterial strains.
Methods: Bacteriophages were isolated from hospital effluent samples by double layer agar method. Isolated phages were propagated by liquid
enrichment technique and its host range was analyzed by double layer agar method. Morphology of the isolated phages was identified by Transmission
Electron Microscope (TEM). Genomic and proteomic analysis was confirmed by electrophoresis technique.
Results & Discussion: 46 bacteriophages were isolated against 20 different MDR and ESBL strains of those 7 phages (Mm81, Ec84, Ps85, En833,
Sal836, Ec8ATCC and Ec8PMG) were selected for further studies. According to the host range analysis result the 7 phage has been shown narrow host
range. The phage genomic DNA and structural proteins were analyzed. In addition to based on the TEM analysis two phages viz., Mm81 and Ec84 were
belongs to Siphoviridae and Podoviridae family respectively. Present study evaluates the extensive occurrence of phages in the hospital effluent. In
addition, this is first report of isolation and characterization of Morganella morganii lytic phage in Tamil Nadu, India.
Conclusion: The study highlights the distribution of bacteriophages in the hospital effluent and it gives the therapeutic potential of isolated phages
for the treatment of MDR and ESBL Producing Pathogens.
Keywords: Phage therapy, Transmission electron microscope, Extended-spectrum of β-lactamase, Multi-drug resistant.
Downloads
References
Sulakvelidze A. Phage therapy: An attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov Today 2005;10(12):807-9.
Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother 2001;45(3):649-59.
Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum -lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Microbiol 2004;22:87-91.
Subbalaxmi MV, Lakshmi V, Lavanya V. Antibiotic resistance – Experience in a tertiary care hospital in south India. J Assoc Physicians India 2010;58 Suppl:18-22.
Jagusztyn-Krynicka EK, Wyszynska A. The decline of antibiotic era – New approaches for antibacterial drug discovery. Pol J Microbiol 2008;57(2):91-8.
Service RF. Orphan drugs of the future? Science 2004;303(5665):1798.
Falconer SB, Brown ED. New screens and targets in antibacterial drug discovery. Curr Opin Microbiol 2009;12(5):497-504.
Deresinski S. Bacteriophage therapy: Exploiting smaller fleas. Clin Infect Dis 2009;48(8):1096-101.
Summers WC. Bacteriophage therapy. Annu Rev Microbiol 2001;55:437-51.
Housby JN, Mann NH. Phage therapy. Drug Discov Today 2009;14(11‑12):536-40.
Alisky J, Iczkowski K, Rapoport A, Troitsky N. Bacteriophages show promise as antimicrobial agents. J Infect 1998;36(1):5-15.
Mesquita MM, Stimson J, Chae GT, Tufenkji N, Ptacek CJ, Blowes DW, et al. Optimal preparation and purification of PRD1-like bacteriophages for use in environmental fate and transport studies. Water Res 2010;44(4):1114-25.
Monk AB, Rees CD, Barrow P, Hagens S, Harper DR. Bacteriophage applications: Where are we now? Lett Appl Microbiol 2010;51(4):363‑9.
Carrillo CL, Abedon ST. Pros and cons of phage therapy. Land Biosci 2011;1(2):111-4.
Carlton RM. Phage therapy: Past history and future prospects. Arch Immunol Ther Exp (Warsz) 1999;47(5):267-74.
Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. Bacteriophage therapy: A revitalized therapy against bacterial infectious diseases. J Infect Chemother 2005;11(5):211-9.
Cerveny KE, DePaola A, Duckworth DH, Gulig PA. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 2002;70(11):6251-62.
Chang HC, Chen CR, Lin JW, Shen GH, Chang KM, Tseng YH, et al. Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5. Appl Environ Microbiol 2005;71(3):1387‑93.
Cornax R, Moriñigo MA, Paez IG, Muñoz MA, Borrego JJ. Application of direct plaque assay for detection and enumeration of bacteriophages of Bacteroides fragilis from contaminated-water samples. Appl Environ Microbiol 1990;56(10):3170-3.
Sillankorva S, Neubauer P, Azeredo J. Isolation and characterization of a T7-like lytic phage for Pseudomonas fluorescens. BMC Biotechnol 2008;8:80.
Adams M. Bacteriophages. New York: Interscience; 1959. p. 137-59.
Sambrook J, Fritsch EF, Maniatis T, editors. Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbour Laboratory Press; 1989. p. 600.
Gupta R, Prasad Y. Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol 2011;62(1):255-60.
Hansen VM, Rosenquist H, Baggesen DL, Brown S, Christensen BB. Characterization of Campylobacter phages including analysis of host range by selected Campylobacter Penner serotypes. BMC Microbiol 2007;7:90.
Mazaheri Nezhad Fard R, Barton MD, Heuzenroeder MW. Novel Bacteriophages in Enterococcus spp. Curr Microbiol 2010;60(6):400-6.
Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbour Laboratory Press; 1982.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227(5259):680-5.
Alam M, Farzana T, Ahsan CR, Yasmin M, Nessa J. Distribution of coliphages against four E. coli virotypes in hospital originated sewage sample and a sewage treatment plant in Bangladesh. Indian J Microbiol 2011;51:188-93.
Sharp R. Review bacteriophages: Biology and history. J Chem Technol Biotechnol 2001;76:667-72.
Zucca M, Savoia D. The post-antibiotic era: Promising developments in the therapy of infectious diseases. Int J Biomed Sci 2010;6(2):77-86.
Lin NT, Chiou PY, Chang KC, Chen LK, Lai MJ. Isolation and characterization of phi AB2: A novel bacteriophage of Acinetobacter baumannii. Res Microbiol 2010;161(4):308-14.32. Mahadevan M, Sundar Nagananda GS, Das A, Bhattacharya S, Suryan S. Isolation of host-specific bacteriophages from sewage against human pathogens. Asian J Biotechnol 2009;1:163-70.
Oliveira A, Sillankorva S, Quinta R, Henriques A, Sereno R, Azeredo J. Isolation and characterization of bacteriophages for avian pathogenic E. coli strains. J Appl Microbiol 2009;106(6):1919-27.
Yamamoto KB, Alberts BM, Benzinger R, Lowhorne L, Treiber G. Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to largescale virus purification. Virology 1970;40(3):734-44.
Huff WE, Huff GR, Rath NC, Balog JM, Donoghue AM. Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poult Sci 2004;83(12):1944-7.
Yang H, Liang L, Lin S, Jia S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 2010;10:131.
Hagens S, Habel A, von Ahsen U, von Gabain A, Bläsi U. Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob Agents Chemother 2004;48(10):3817-22.
Ackermann HW, Nguyen TM. Sewage coliphages studied by electron microscopy. Appl Environ Microbiol 1983;45(3):1049-59.
Ackermann HW, Dubow MS, Gershman M, Wysocki KB, Kasatiya SS, Loessner MJ, et al. Taxonomic changes in phages of enterobacteria. Arch Virol 1997;142:1381-90.
Zhu J, Rao X, Tan Y, Xiong K, Hu Z, Chen Z, et al. Identification of lytic bacteriophage MmP1, assigned to a new member of T7-like phages infecting Morganella morganii. Genomics 2010;96(3):167-72.
Kumari S, Harjai K, Chhibber S. Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol (Praha) 2010;55(3):221-7.
Eyer L, Pantucek R, Zdráhal Z, Konecná H, Kaspárek P, Ruzicková V, et al. Structural protein analysis of the polyvalent staphylococcal bacteriophage 812. Proteomics 2007;7(1):64-72.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.